healthcare
UK Stocks Close Higher, Bolstered by Banks and Healthcare Stocks
FinanceUK Competition Watchdog to Probe PHP's $2.4 Billion Takeover of Assura
Arrowhead, Novartis in up to $2 Billion Deal for Neuromuscular Therapy License
UK Sets Out Support for Afghanistan Earthquake Victims
Stoxx 600 Ends Higher on Defence Boost; Novo Nordisk Jumps After Wegovy Data
Date: September 1, 2025
(Reuters) -European shares edge higher on Monday, supported by healthcare stocks after data showed Danish drugmaker Novo Nordisk's weight-loss drug Wegovy offered better heart-protective benefits than...
CapVest to Acquire Majority Stake in Stada, Ending German Firm's IPO Plans
Date: September 1, 2025
FRANKFURT (Reuters) -Buyout firm CapVest Partners is to acquire a majority stake in Stada Arzneimittel, the German generic drugmaker said on Monday, in what is set to become one of the biggest...
AstraZeneca to Seek Approval for Blood Pressure Drug by Year-End
Date: August 30, 2025
By Pushkala Aripaka (Reuters) -AstraZeneca plans to file for regulatory approval of its experimental blood pressure treatment before the end of the year, a senior company executive said, about a...
UK Approves GSK's Antibiotic for Female Urinary Tract Infections
Date: August 27, 2025
(Reuters) -Britain's Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday said it approved gepotidacin, also known as Blujepa, a new kind of oral antibiotic pill to treat...
Eli Lilly Temporarily Halts UK Shipments of Weight-Loss Drug Mounjaro
Date: August 27, 2025
(Reuters) -Eli Lilly has temporarily paused shipments of its weight-loss drug Mounjaro in the UK, ahead of a new price hike for the treatment set to come into effect starting next month. Lilly said...
EU Approves Gilead's New Injection for Preventing Hiv
Date: August 26, 2025
By Deena Beasley (Reuters) -The European Commission has granted marketing authorization for Gilead Sciences' twice-yearly injection for preventing HIV infection, the company said on Tuesday. The drug,...